Conference item
The impact of a virtual clinic on clinical decision-making and healthcare resource use vs. standard care: The Oxford experience
- Abstract:
- Optimisation of infliximab (IFX) therapy using proactive therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD) may reduce drug costs and improve clinical outcomes. The Oxford Virtual Clinic (VC) for biological therapy TDM was started in March 2016. Levels are monitored with each infusion and therapy optimised if clinically appropriate.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
- Publisher:
- Oxford University Press
- Host title:
- 13th Congress of the European Crohn's and Colitis Organisation (ECCO 2018)
- Journal:
- 13th Congress of the European Crohn's and Colitis Organisation (ECCO 2018) More from this journal
- Publication date:
- 2018-01-26
- Acceptance date:
- 2017-12-22
- DOI:
- ISSN:
-
1873-9946 and 1876-4479
- Pubs id:
-
pubs:844192
- UUID:
-
uuid:5c218101-2593-4227-9abc-e329ea37b5d1
- Local pid:
-
pubs:844192
- Source identifiers:
-
844192
- Deposit date:
-
2018-04-27
Terms of use
- Copyright date:
- 2018
If you are the owner of this record, you can report an update to it here: Report update to this record